WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2013160810) NOVEL BETULINIC ACID DERIVATIVES AS HIV INHIBITORS
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2013/160810 International Application No.: PCT/IB2013/053120
Publication Date: 31.10.2013 International Filing Date: 19.04.2013
IPC:
A61K 31/4965 (2006.01)
Applicants: PANDURANGA ADULLA, Reddy[US/IN]; IN (US)
HETERO RESEARCH FOUNDATION[IN/IN]; Hetero Drugs Ltd, Plot No: B-80 & 81, A.P.I.E., Balanagar, Hyderabad Andhra Pradesh 500018, IN
Inventors: PANDURANGA ADULLA, Reddy; IN
PARTHASARADHI REDDY, Bandi; IN
MANOHAR SHARMA, Vedula; IN
RATHNAKAR REDDY, Kura; IN
PREM KUMAR, Mamnoor; IN
BHASKAR REDDY, Kasireddy; IN
NARSINGAM, Mogili; IN
VENKATI, Mukkera; IN
VL SUBRAHMANYAM, Lanka; IN
MALLIKARJUN REDDY, Ravi; IN
Agent: PELLETIER, Roberta L.; Cantor Colburn Llp 20 Church Street 22nd Floor Hartford, Connecticut 06103, US
Priority Data:
1613/CHE/201224.04.2012IN
5528/CHE/201231.12.2012IN
Title (EN) NOVEL BETULINIC ACID DERIVATIVES AS HIV INHIBITORS
(FR) NOUVEAUX DÉRIVÉS D'ACIDE BÉTULINIQUE À TITRE D'INHIBITEURS DU VIH
Abstract: front page image
(EN) The present invention provides betulinic acid derivatives and related compounds, which may be used as antiviral particularly as anti-HIV compounds and processes for the synthesis of these compounds. Pharmaceutically acceptable salts, pharmaceutically acceptable solvates, enantiomers, diastereomers, together with pharmaceutically acceptable carriers, excipients or diluents, which can be used for the treatment of diseases, condition and/or disorders mediated by viral infections, are also provided.
(FR) (I) Cette invention concerne de nouveaux dérivés d'acide bétulinique et autres composés apparentés, et des compositions pharmaceutiques utiles pour le traitement thérapeutique des maladies virales et en particulier des maladies médiées par le VIH.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)